Infliximab trials for Ulcerative colitis

All Infliximab trials · All Ulcerative colitis trials

Phase breakdown

Recruiting trials studying Infliximab for Ulcerative colitis

• Comparison of Ustekinumab, Infliximab and Combination Therapy in Moderately to Severely Active Ulcerative Colitis
  NCT06453317 · Phase: Phase 2 · Ages: 18 Years to 64 Years · Sex: All (male and female) · 1 location
• PROactive and Early Infliximab Monitoring and OPTimization in Inflammatory Bowel Disease
  NCT06758024 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 75 Years · Sex: All (male and female) · 2 locations
• Subcutaneous Infliximab After A Previous Intravenous Dose Optimization
  NCT06113913 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 30 locations
• Top Down Versus Step up in Pediatric Ulcerative Colitis
  NCT04999228 · Phase: Phase 4 · Ages: 6 Years to 18 Years · Sex: All (male and female) · 1 location
• Upadacitinib Versus Infliximab as Second-Line Treatment for Acute Severe Ulcerative Colitis（UPRISE）
  NCT07550673 · Phase: Phase 4 · Ages: 18 Years to 85 Years · Sex: All (male and female) · 4 locations

Common questions

How many trials study Infliximab for Ulcerative colitis?

5 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.